These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7307430)

  • 1. Antipyrine and warfarin disposition in a patient with idiopathic hypoalbuminemia.
    Piroli RJ; Passananti GT; Shively CA; Vesell ES
    Clin Pharmacol Ther; 1981 Dec; 30(6):810-6. PubMed ID: 7307430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic differences in reactions to drugs and xenobiotics. Other protein variants with pharmacogenetic consequences: albumin and orosomucoid.
    Alván G
    Prog Clin Biol Res; 1986; 214():345-55. PubMed ID: 3523512
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of oral high-dose progestins on the disposition of antipyrine, digitoxin, and warfarin in patients with advanced breast cancer.
    Lundgren S; Kvinnsland S; Utaaker E; Bakke O; Ueland PM
    Cancer Chemother Pharmacol; 1986; 18(3):270-5. PubMed ID: 2948732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of coumarin anticoagulants. XIV: relationship between protein binding, distribution, and elimination kinetics of warfarin in rats.
    Yacobi A; Levy G
    J Pharm Sci; 1975 Oct; 64(10):1660-4. PubMed ID: 1195101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.
    Vesell ES; Passananti GT; Glenwright PA; Dvorchik BH
    Clin Pharmacol Ther; 1975 Sep; 18(3):259-72. PubMed ID: 1164816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of carbon tetrachloride (CCl4) induced liver damage on the volume of distribution, the elimination half-life and body clearance of antipyrine and warfarin in rabbits.
    Ladefoged O
    Acta Vet Scand; 1979; 20(3):429-37. PubMed ID: 506875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinine-induced alterations in drug disposition.
    Berlin CM; Stackman JM; Vesell ES
    Clin Pharmacol Ther; 1975 Dec; 18(6):670-9. PubMed ID: 1204275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors.
    Ganeval D; Fischer AM; Barre J; Pertuiset N; Dautzenberg MD; Jungers P; Houin G
    Clin Nephrol; 1986 Feb; 25(2):75-80. PubMed ID: 3698349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of albumin and alpha-1 acid glycoprotein on elimination of prazosin and antipyrine in the isolated perfused rat liver.
    Oie S; Fiori F
    J Pharmacol Exp Ther; 1985 Sep; 234(3):636-40. PubMed ID: 4032284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipyrine disposition and liver size in the elderly.
    Swift CG; Homeida M; Halliwell M; Roberts CJ
    Eur J Clin Pharmacol; 1978 Nov; 14(2):149-52. PubMed ID: 720377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoalbuminemia as a risk factor for over-anticoagulation.
    Tincani E; Mazzali F; Morini L
    Am J Med; 2002 Feb; 112(3):247-8. PubMed ID: 11893361
    [No Abstract]   [Full Text] [Related]  

  • 12. Morphologic, biochemical and physiologic alterations in a case of idiopathic hypoalbuminemia (analbuminemia).
    Weinstock JV; Kawanishi H; Sisson J
    Am J Med; 1979 Jul; 67(1):132-9. PubMed ID: 463906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
    Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
    Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipyrine kinetics in undernourished diabetics.
    Shobha JC; Raghuram TC; Kumar AD; Krishnaswamy K
    Eur J Clin Pharmacol; 1991; 41(4):359-61. PubMed ID: 1804653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effect of Cl2Ca and Cl2Mg on warfarin-human serum albumin (HSA) binding.
    Pérez Gallardo L
    Magnes Res; 1999 Mar; 12(1):43-8. PubMed ID: 10192099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of fenfluramine on disposition and rate of antipyrine elimination.
    O'Malley K; Stevenson IH; West M
    Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipyrine kinetics in Nigerian women in chronic renal failure.
    Iyun AO; Tucker GT
    Afr J Med Med Sci; 1982 Mar; 11(1):7-9. PubMed ID: 6291357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic lever disease.
    Branch RA; James JA; Read AE
    Clin Pharmacol Ther; 1976 Jul; 20(1):81-9. PubMed ID: 1277728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of alpha-1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarin.
    Urien S; Albengres E; Pinquier JL; Tillement JP
    Clin Pharmacol Ther; 1986 Jun; 39(6):683-9. PubMed ID: 3709033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.